Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer
NCT01218490 · Status: SUSPENDED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 450
Last updated 2019-05-16
Summary
It is a multicenter randomized trial of superior cleaning compared the absence of dissection in stage III patients with optimal surgical resection without retroperitoneal lymph node palpable.
Conditions
Interventions
- PROCEDURE
-
ovarian cancer surgery
Sponsors & Collaborators
-
Institut Cancerologie de l'Ouest
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-12-09
- Primary Completion
- 2026-05-31
- Completion
- 2026-05-31
Countries
- France
Study Locations
More Related Trials
-
Debulking Surgery in Ovarian Cancer
NCT03378128 ·Status: COMPLETED ·Phase: NA
-
Minimally Invasive Interval Debulking Surgery in Advanced Ovarian Cancer
NCT07031908 ·Status: NOT_YET_RECRUITING
-
Trial on Radical Upfront Surgery in Advanced Ovarian Cancer
NCT02828618 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
NCT00003120 ·Status: COMPLETED ·Phase: PHASE3
-
Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer
NCT00002894 ·Status: COMPLETED ·Phase: PHASE3
-
Timing of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
NCT00075712 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Role of Surgery in Advanced Ovarian Cancer
NCT03980028 ·Status: COMPLETED
-
Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standard Chemotherapy in Patients With Ovarian Cancer
NCT01462890 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Impact on Survival of a Paradigm Shift in the Therapeutic Strategy of Patients With Advanced Ovarian Cancer
NCT06907771 ·Status: RECRUITING
-
Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer
NCT00002895 ·Status: COMPLETED ·Phase: PHASE3
-
OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206
NCT00112086 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma
NCT01519869 ·Status: COMPLETED ·Phase: PHASE2
-
Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
NCT01468909 ·Status: COMPLETED ·Phase: PHASE2
-
Mapping Sentinel Lymph Node in Initial Stages of Ovarian Cancer
NCT05184140 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Chemotherapy Influence on Clinical and Biological Markers of Ovarian Reserve
NCT00712452 ·Status: TERMINATED ·Phase: NA
-
Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
NCT00331422 ·Status: TERMINATED ·Phase: PHASE2
-
Pretherapeutic Paraaortic Lymphadenectomy in Women With Locally Advanced Cervical Cancer Versus Definitive Chemoradiotherapy
NCT02848716 ·Status: WITHDRAWN ·Phase: PHASE3
-
Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer
NCT05236686 ·Status: RECRUITING ·Phase: NA
-
Chemotherapy With or Without Surgery in Treating Patients With Stage II or Stage III Ovarian Cancer
NCT00003695 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Systematic Imaging for Follow up of Patients With Ovarian, Fallopian Tube or Primary Peritoneum Cancer
NCT04826029 ·Status: WITHDRAWN ·Phase: NA
-
Real-life Data of Olaparib in Relapsed Ovarian Cancers Patients
NCT04152941 ·Status: COMPLETED
-
STOP OVarian CAncer; Implementation of the Opportunistic Salpingectomy in the Netherlands
NCT04470921 ·Status: ACTIVE_NOT_RECRUITING
-
Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging
NCT06084195 ·Status: RECRUITING ·Phase: NA
-
Postoperative Adjuvant Chemotherapy With Bevacizumab and Maintenance Bevacizumab After Neoadjuvant Chemotherapy for Ovarian Cancer
NCT02022917 ·Status: COMPLETED ·Phase: PHASE2
-
Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
NCT00004934 ·Status: COMPLETED ·Phase: PHASE3